The Use and Cost of HIV Service Provision in England in 1996

No abstract is available for this paper.

• Publication year

  1998

• Venue

  PharmacoEconomics (Auckland)

• Publication date

  1998-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00019053-199814060-00005PMID 10346416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee.

  1998cited by this paper
• Surrogacy in HIV-1 clinical trials.

  1998cited by this paper
• Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.

  1998cited by this paper
• Antiretroviral Therapy for HIV Infection

  1998cited by this paper
• 12th World AIDS Conference.

  1998cited by this paper
• Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy

  1998cited by this paper
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee.

  1997cited by this paper
• Decay characteristics of HIV-1-infected compartments during combination therapy

  1997cited by this paper
• British HIV Association guidelines for antiretroviral treatment of HIV Seropositive individuals.

  1997cited by this paper
• Current problems and the future of antiretroviral drug trials.

  1997cited by this paper
• Hospital care for persons with AIDS in the European Union.

  1997cited by this paper
• British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals.

  1997cited by this paper
• Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

  1997cited by this paper
• Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.

  1996cited by this paper
• A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

  1996cited by this paper
• The use and cost of hospital services by London AIDS patients with different AIDS defining conditions.

  1996cited by this paper
• Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter

  1996cited by this paper
• Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.

  1996cited by this paper
• Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel

  1996cited by this paper
• Survival and the use and costs of hospital services for London AIDS patients treated with AZT.

  1996cited by this paper
• Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

  1996cited by this paper
• Advances in antiretroviral therapy and viral load monitoring.

  1996cited by this paper
• Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals

  1996cited by this paper
• Cost and utilisation of community services for people with HIV infection in London.

  1995cited by this paper
• The economic and social impact of AIDS in Europe.

  1995cited by this paper
• Hospital costs of treating haetnophilic patients infected with HIV

  1995cited by this paper
• In-patient care for symptomatic, HIV-infected persons: a longitudinal study of hospitalizations, in-patient drug use, and related costs.

  1995cited by this paper
• Hospital Service Utilization by HIV/AIDS Patients and Their Management Cost in a Provincial Genitourinary Medicine Department

  1995cited by this paper
• Changing use of hospital services and costs at a London AIDS referral centre, 1983–1989

  1994cited by this paper
• Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre

  1994cited by this paper
• Patterns of hospital care for patients with HIV infection and AIDS.

  1993cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• The cost of caring for patients with HIV infection in hospice.

  1991cited by this paper
• The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district.

  1986cited by this paper
• The distinction between cost and charges.

  1982cited by this paper

• What services, interventions and support are available for People with HIV in England to manage their overall health and wellbeing? A scoping review

  2025influential citation
• The efficiency of the EmERGE pathway of care for people living with HIV in England

  2022cites this paper
• Economic impact of HIV/AIDS: a systematic review in five European countries

  2014cites this paper
• Effect of management strategies and clinical status on costs of care for advanced HIV.

  2014cites this paper
• Use and cost of antiretrovirals in France 1995–2000

  2012cites this paper
• The Cost of HIV Treatment and Care

  2012cites this paper
• Use and Cost of Hospital and Community Service Provision for Children with HIV Infection at an English HIV Referral Centre

  2012cites this paper
• Cost-effectiveness of staff and workload profiles in retaining patients on antiretroviral therapy in KwaZulu-Natal, South Africa

  2011cites this paper
• Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006

  2011cites this paper
• Cost-effectiveness study comparing pharmaceutically licensed plasma for transfusion (OctaplasLG®) versus fresh frozen plasma (FFP) in critically Ill patients in the UK

  2010cites this paper
• Cost-effectiveness study comparing pharmaceutically licensed plasma for transfusion (OctaplasLG®) versus fresh frozen plasma (FFP) in critically Ill patients in the UK.

  2010cites this paper
• Comparison of HIV-infected patients’ characteristics, healthcare resources use and cost between native and migrant patients

  2009cites this paper
• Socio-economic impact of antiviral intervention.

  2009cites this paper
• Treatment Outcome and Cost-Effectiveness of Different Highly Active Antiretroviral Therapy Regimens in the Uk (1996–2002)

  2008cites this paper
• Cost and cost-effectiveness of antiretroviral therapy for HIV infection in Singapore

  2006cites this paper
• The cost-effectiveness of highly active antiretroviral therapy, Canada 1991–2001

  2004cites this paper
• Lifetime Cost of HIV Care in France during the Era of Highly Active Antiretroviral Therapy

  2001cites this paper
• The Impact of New Antiretroic Therapeutic Schemes on the Cost for AIDS Treatment in Greece

  2001cites this paper
• The cost of HIV treatment and care. A global review.

  2001cites this paper
• Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy

  2001cites this paper
• HIV-1 Drug Resistance Genotyping

  2000cites this paper
• Indirect cost of HIV infection in England.

  2000cites this paper
• HIV-1 drug resistance genotyping. A review of clinical and economic issues.

  2000cites this paper
• Use and cost of hospital services by HIV-infected children during the era of antiretroviral monotherapy.

  1999cites this paper
• What is the cost of getting the price wrong?

  1999cites this paper
• Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. National Prospective Monitoring System Steering Group.

  1999cites this paper